Transcenta Holding
transcenta.com
Actively hiring
Bioprocessing
Health Care
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
501-1000
employees, estimated range
Backers
2
ARCH Venture Partners, Fortune Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
ARCH Venture Partners 
Fortune Capital Similar startupsby what they do, their industry and backers
At Frontier Space, we enable next-generation biotechnology R&D in orbit—providing microgravity platforms for protein crystallisation, cell…
Learn how Dispatch Biotherapeutics is expanding the curative potential of immunotherapies by dispatching its Flare platform to overcome…
Isoform Oncology is a new biotech exploiting isoform switching and alternative splicing for the development of new biotherapeutics.
Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Accelerate time to market and increase throughput with Ark’s high-fidelity bioprocess simulation software.
We made the impossible possible. Monitor, analyze, and optimise your bioprocesses in real time with BioIntelligence — the industrial…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hangzhou
China
Regional office
Hangzhou
500-1000 est. staff
Building 3, Hangzhou Pharmaceutical Town, No.291 Fucheng Road, Hangzhou, China